The 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay is used as a major method to evaluate cell viability. However, in some cases, the results may reflect mitochondr...
supported by grants from the National Natural Science Foundation(No.81702419);the National Science Fund for Distinguished Young Scholars(No.82000497);the Key Research and Development Plan of Jiangsu Province(Nos.BE2019692 and BE2020668);the Natural Science Foundation of Jiangsu Province(Nos.BK20211105 and BK20200965);the Postdoctoral Science Foundation of China(No.2019M661909);the Social Development Foundation of Nantong City(Nos.MS22020005 and MSZ20076);the Postgraduate Research&Practice Innovation Program of Jiangsu Province(Nos.KYCX20_2681,KYCX20_2673,and KYCX21_3112).
Pancreatic cancer is one of the most lethal neoplasms with high metastatic potential and is resistant to almost all current therapies.Epalrestat is an aldo-keto reductase family 1 member B1(AKR1B1)inhibitor for the tr...
2019 Hainan Province Medical and Health Research Project(No.1901320244S2007)。
Objective:To investigate the effect of Epalrestat combined with Huoxue Huayu preparation on early diabetic retinopathy and its effect on serum oxidative stress and inflammatory factors.Methods:132 patients with early ...
We thank Ms Fahmida Zaman for her initial intellectual support for this project;We are grateful to Ms Noshin Noorjahan for her editorial support for our manuscript.Department of Pharmaceutical Sciences at North South University provided the Laboratory space,including the equipment and basic reagents necessary to conduct this project.
Background:Parkinson's disease(PD)is a progressive neurodegenerative disorder affecting a large number of elderly people worldwide.The current therapies for PD are symptom-based;they do not provide a cure but improve ...
Drug stability is closely related to drug safety and needs to be considered in the process of drug production,package and storage.To investigate the stability of epalrestat,a carboxylic acid derivative,a reversed-phas...
the National Natural Science Foundation of the People's Republic of China (81530098);the National Key Special Project of Science and Technology for Innovation Drugs of China (2017ZX09301013,2015ZX09501001);the Natural Science Foundation of Jiangsu Province (BL2014070);the project of university collaborative innovation center of Jiangsu province (Modern Chinese Medicine Center and Biological Medicine Center).
Epalrestat is an inhibitor of aldose reductase in the polyol pathway and is used for the management of diabetic neuropathy clinically.Our pilot experiments and accumulated evidences showed that epalrestat inhibited po...
supported by the National Natural Science Foundation of China,No.81370165;a grant from the Public Benefit Technology and Society Development Program of Zhejiang Province of China,No.2015C33309;a grant from the Ningbo Science and Technology Innovation Team Program in China,No.2014B82002,2015B11050;a grant from the Ningbo Science and Technology Project in China,No.2015A610217;the Fang Runhua Fund of Hong Kong,K.C.Wong Magna Fund in Ningbo University
OBJECTIVE: To evaluate the efficacy of α-lipoic acid(ALA) plus epalrestat combination therapy in the treatment of diabetic peripheral neuropathy(DPN). DATA SOURCES: The electronic databases of Pub Med, Medline,...
Objective:To study the renal function, peroxidation damage and inflammatory injury after epalrestat combined with alprostadil treatment of early diabetic nephropathy.Methods:90 patients with early diabetic nephropathy...
Objective:To explore the influence of adjuvant epalrestat treatment of early diabetic nephropathy on renal function and oxidative stress.Methods:A total of 80 patients with early diabetic nephropathy who were treated ...